This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

HAEMATO Past Earnings Performance

Past criteria checks 4/6

HAEMATO has been growing earnings at an average annual rate of 15.3%, while the Healthcare industry saw earnings declining at 0.9% annually. Revenues have been growing at an average rate of 0.8% per year. HAEMATO's return on equity is 6.4%, and it has net margins of 3.7%.

Key information

15.3%

Earnings growth rate

-11.1%

EPS growth rate

Healthcare Industry Growth	15.7%
Revenue growth rate	0.8%
Return on equity	6.4%
Net Margin	3.7%
Last Earnings Update	30 Jun 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How HAEMATO makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:HAEK Revenue, expenses and earnings (EUR Millions)
Date	Revenue	Earnings	G+A Expenses
30 Jun 23	261	10	4
31 Mar 23	254	9	5
31 Dec 22	248	8	5
30 Sep 22	251	4	6
30 Jun 22	254	0	7
31 Mar 22	270	3	7
31 Dec 21	285	7	8
30 Sep 21	280	6	7
30 Jun 21	274	5	7
31 Mar 21	256	0	7
31 Dec 20	238	-5	7
30 Sep 20	229	-3	7
30 Jun 20	220	-2	7
31 Mar 20	209	-2	7
31 Dec 19	198	-1	6
30 Sep 19	211	-1	6
30 Jun 19	224	-1	6
31 Mar 19	249	3	6
31 Dec 18	274	6	6
30 Sep 18	284	8	6
30 Jun 18	294	10	6
31 Mar 18	292	8	6
31 Dec 17	289	7	6
30 Sep 17	281	8	6
30 Jun 17	272	9	5
31 Mar 17	274	10	5
31 Dec 16	276	11	5
30 Sep 16	273	9	5
30 Jun 16	271	7	6
31 Mar 16	250	6	6
31 Dec 15	230	6	5
30 Sep 15	210	5	7
30 Jun 15	190	5	5
31 Mar 15	196	6	5
31 Dec 14	203	7	5
30 Sep 14	214	9	-1
30 Jun 14	224	10	4
31 Mar 14	199	9	4
31 Dec 13	174	8	0
30 Sep 13	126	7	3
30 Jun 13	79	7	2

Quality Earnings: HAEK has a large one-off gain of €2.9M impacting its last 12 months of financial results to 30th June, 2023.

Growing Profit Margin: HAEK's current net profit margins (3.7%) are higher than last year (0.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HAEK's earnings have grown by 15.3% per year over the past 5 years.

Accelerating Growth: HAEK's earnings growth over the past year (2578%) exceeds its 5-year average (15.3% per year).

Earnings vs Industry: HAEK earnings growth over the past year (2578%) exceeded the Healthcare industry -2.2%.

Return on Equity

High ROE: HAEK's Return on Equity (6.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/06/05 06:49
End of Day Share Price	2024/04/17 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HAEMATO AG is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Edward Acklin	First Berlin Equity Research GmbH
Cosmin Filker	GBC AG
Christian Ehmann	Warburg Research GmbH